Phase II study of the human anti-epithelial cell adhesion molecule antibody adecatumumab in prostate cancer patients with increasing serum levels of prostate-specific antigen after radical prostatectomy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples